Bapineuzumab and solanezumab for Alzheimer's disease: is the `amyloid cascade hypothesis' still alive?

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.7, 2013-09, pp. : 1075-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solanezumab for Alzheimer's disease

By Samadi Hossein Sultzer David

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 787-798

Informa Healthcare

Access to resources Recommend Favorite

Closing in on the amyloid cascade: Recent insights into the cell biology of Alzheimer’s disease

By Huse Jason Doms Robert

Molecular Neurobiology, Vol. 22, Iss. 1-3, 2000-12 ,pp. : 81-98

Humana Press, Inc

Access to resources Recommend Favorite

Can I Smell Gas (or Is It Lilac)? Olfactory Semantic Deficits in Mild Cognitive Impairment and Alzheimer's Disease

By Bahar-Fuchs Alex

Chemosensory Perception, Vol. 3, Iss. 2, 2010-06 ,pp. : 118-128

Springer Publishing Company

Access to resources Recommend Favorite

Oxidative Stress Hypothesis in Alzheimer's Disease

By Markesbery W.R.

Free Radical Biology and Medicine, Vol. 23, Iss. 1, 1997-01 ,pp. : 134-147

Elsevier

Access to resources Recommend Favorite

Bapineuzumab

By Kerchner Geoffrey A Boxer Adam L

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1121-1130

Informa Healthcare

Access to resources Recommend Favorite